Track Pear Therapeutics's net tangible assets ($31M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (December 2022), PEAR shows a net tangible assets of $31M. That compares with $90M in the prior-year period — down 66.2% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, PEAR's net tangible assets is now $31M (was $90M) — a 66.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Pear Therapeutics is outperforming or lagging.
Tracking PEAR's net tangible assets over time shows whether Pear Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $31M That compares with $90M in the prior-year period — down 66.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this net tangible assets page, Stockcircle has Pear Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $31M) with ownership activity and broader fundamentals.